Stay updated on PATHWay Study: Adjuvant Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the PATHWay Study: Adjuvant Pembrolizumab Clinical Trial page.

Latest updates to the PATHWay Study: Adjuvant Pembrolizumab Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, indicating a newer edition of the page content. This change reflects maintenance/versioning activity and does not modify the study details.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe revision was updated from v3.6.3 to v3.6.4. This marks the deployment of a newer page version.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page now shows revision v3.6.3, replacing the previous v3.6.2, indicating a minor update to the page's versioning information.SummaryDifference0.1%

- Check59 days agoChange DetectedA new revision tag v3.6.2 has been added and the previous v3.6.0 tag was removed, indicating an updated version of the page’s revision history.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page adds a recruitment status notice indicating no further participant enrollment and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also changes the heading formatting from 'Intervention / Treatment' to 'Intervention/Treatment' and removes the 'Revision: v3.5.5' text, reflecting an updated site version.SummaryDifference0.4%

- Check81 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5. This indicates a new administrative refresh of the study record.SummaryDifference0.1%

Stay in the know with updates to PATHWay Study: Adjuvant Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PATHWay Study: Adjuvant Pembrolizumab Clinical Trial page.